"There's patent litigation right now over the God molecule. I just think it's the most absurd thing."
What happens when an ethereal, ego-dissolving experience runs headlong into big pharma? Dan Corder chats to journalist Kimon de Greef on The Ego Trip, and the strange final act of the toad story: 5-MeO-DMT quietly becoming one of the smart bets to be the next clinical psychedelic treatment. They talk about why a half-hour trip is so seductive to a market-driven industry, the patent wars already breaking out over the God molecule, and the push to administer it without any accompanying...